Literature DB >> 8814759

Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes.

J Ferris.   

Abstract

Mesh:

Year:  1996        PMID: 8814759      PMCID: PMC505420          DOI: 10.1136/bjo.80.2.189-a

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes.

Authors:  T Hikichi; A Yoshida; J Akiba; C L Trempe
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

2.  Prognosis of stage 2 macular holes.

Authors:  T Hikichi; A Yoshida; J Akiba; S Konno; C L Trempe
Journal:  Am J Ophthalmol       Date:  1995-05       Impact factor: 5.258

3.  Use of intravitreal autologous blood to identify posterior cortical vitreous in macular hole surgery.

Authors:  E A Ryan; S Lee; S Chern
Journal:  Arch Ophthalmol       Date:  1995-06

4.  Vitreous surgery for idiopathic macular holes. Results of a pilot study.

Authors:  N E Kelly; R T Wendel
Journal:  Arch Ophthalmol       Date:  1991-05

5.  Effect of the vitreous on the prognosis of full-thickness idiopathic macular hole.

Authors:  T Hikichi; J Akiba; C L Trempe
Journal:  Am J Ophthalmol       Date:  1993-09-15       Impact factor: 5.258

6.  Pars plana vitrectomy for treatment of stage 2 macular holes.

Authors:  A J Ruby; D F Williams; M G Grand; M A Thomas; T A Meredith; I Boniuk; R J Olk
Journal:  Arch Ophthalmol       Date:  1994-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.